Author:
Debus E. Sebastian,Grundmann Reinhart T.
Publisher
Springer Berlin Heidelberg
Reference23 articles.
1. Aboyans V, Ricco JB, Bartelink MEL et al (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816
2. Anderson JL, Halperin JL, Albert NM et al (2013) Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:1425–1443
3. Balk EM, Raman G, Adam GP, Halladay CW, Langberg VN, Azodo IA, Trikalinos TA (2016) Renal artery stenosis management strategies: an updated comparative effectiveness review [Internet]. Agency for Healthcare Research and Quality (US), Rockville; Report No.: 16-EHC026-EF. AHRQ Comparative Effectiveness Reviews
4. Bradaric C, Eser K, Preuss S, Dommasch M, Wustrow I, Langwieser N, Haller B, Ott I, Fusaro M, Heemann U, Laugwitz KL, Kastrati A, Ibrahim T (2017) Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease. EuroIntervention 13:e248–e255
5. Catena C, Colussi G, Brosolo G, Verheyen N, Novello M, Bertin N, Cavarape A, Sechi LA (2017) Long-term renal and cardiac outcomes after stenting in patients with resistant hypertension and atherosclerotic renal artery stenosis. Kidney Blood Press Res 42:774–783